Peter J. Parker

from Wikipedia, the free encyclopedia

Peter Joseph Jacques Parker FRS (born September 30, 1954 ) is a British biochemist and cancer researcher .

Life

Parker graduated from the University of Oxford a bachelor in biochemistry and 1979 when Philip Randle also in Oxford his Ph.D. , also in biochemistry. After research positions as a postdoctoral fellow for the Medical Research Council (MRC) in Dundee and the Imperial Cancer Research Fund (ICRF) in London, he became head of a research laboratory at the ICRF in 1985 and at the Ludwig Institute for Cancer Research in 1986 . In 1990 he became Principal Investigator at the ICRF, which was renamed Cancer Research UK in 2002 . Parker became Head of Cancer Studies at King's College London in 2006 and Group Leader at the Francis Crick Institute , also in London, from 2015 , which is the successor to Cancer Research UK's London Research Institute . He is a professor at King's College.

Services

Parker's research interests include signal transduction , biomarkers , oncology, and molecular cell biology . Work on protein kinase C is one of his most highly regarded research achievements .

In about 20 years of research, Peter Parker has authored or co-authored over 300 specialist articles. Several of them have been cited over 1000 times. Parker has an h-index between 89 and 99 , depending on the source. He is involved in several patent applications in his field.

honors and awards

In 1997 Parker was elected to the European Molecular Biology Organization , 2006 as a member ( Fellow ) to the Royal Society .

Publications (selection)

  • L. Coussens, PJ Parker, L. Rhee, TL Yangfeng, E. Chen, MD Waterfield, U. Francke, A. Ullrich: Multiple, Distinct Forms of Bovine and Human Protein-Kinase-C Suggest Diversity in Cellular Signaling Pathways . In: Science . tape 233 , no. 4766 , August 22, 1986, pp. 859-866 , doi : 10.1126 / science.3755548 .
  • L.V. Dekker, P.J. Parker: Protein Kinase-C - a Question of Specificity . In: Trends in Biochemical Sciences . tape 19 , no. 2 , February 1994, p. 73-77 , doi : 10.1016 / 0968-0004 (94) 90038-8 .
  • JA Le Good, WH Ziegler, DB Parekh, DR Alessi, P. Cohen, PJ Parker: Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1 . In: Science . tape 281 , no. 5385 , September 25, 1998, pp. 2042–2045 , doi : 10.1126 / science.281.5385.2042 .
  • H. Mellor, PJ Parker: The extended protein kinase C superfamily . In: Biochemical Journal . tape 332 , June 1, 1998, pp. 281-292 .
  • B. Vanhaesebroeck, SJ Leevers, K. Ahmadi, J. Timms, R. Katso, PC Driscoll, R. Woscholski, PJ Parker, MD Waterfield: Synthesis and function of 3-phosphorylated inositol lipids . In: Annual Review of Biochemistry . tape 70 , 2001, p. 535-602 , doi : 10.1146 / annurev.biochem.70.1.535 .

Individual evidence

  1. ^ Peter Parker: PKC signaling in cell proliferation and cancer. Francis Crick Institute , accessed January 1, 2016 .
  2. ^ Head of the Division: Professor Peter Parker. Division of Cancer Studies, King's College London , accessed January 1, 2016 .
  3. ^ Peter Parker: Biography. Francis Crick Institute , accessed January 1, 2016 .
  4. a b Peter Parker. Royal Society , accessed January 1, 2016 .
  5. ^ Parker PJ - Author. In: PubMed . Accessed January 1, 2016 (list of articles).
  6. ^ Web of Science Search. In: Web of Science . Retrieved on January 1, 2016 (search for “Author Identifier: D-5192-2013”) provides 297 specialist articles from the period from 1993 to 2013. The articles have a total of 30,739 citations and result in an h-index of 90. Three of the articles are each cited over 1000 times).
  7. Peter Parker D-5192-2013. In: ResearcherID .com. Retrieved January 1, 2016 .
  8. Peter Parker. In: Google Scholar . Retrieved January 1, 2016 .
  9. Patent applications via the DPMA: Az. E058108242 , Az. E939080289 , Az. E060122462